History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.
2026-10-10 18:15
•Matt Dilallo •The Motley Fool
••••• • Axe Cap view
Abbott Labs: A Rare Healthcare Growth and Income Play
With steady earnings growth and 54 years of rising dividends, Abbott looks like a solid long-term pick for defensive portfolios.
Abbott Laboratories stands out as a healthcare stock that combines reliable income with growth. Over the past decade, it has grown earnings per share by about 9.7% annually and boosted dividends for 54 straight years, making it a true Dividend King. This kind of consistency is rare in any market. On top of that, conservative analyst estimates suggest the stock could double by 2036. For South African investors, Abbott’s defensive profile is valuable now, as volatility stirs concerns about local banks and retailers tied to the rand's swings. Abbott’s global healthcare exposure makes it less sensitive to rand weakness, providing portfolio ballast. The 2.5% dividend yield also helps offset lower yields locally. However, one risk is that currency fluctuations between the USD and ZAR might diminish returns when converted back, especially if the rand weakens further. Still, if you’re looking beyond the JSE’s standout counters like Naspers or AngloGold, Abbott offers real diversification and dependable returns. this is just our opinion and not financial advice
I would buy Abbott for a mix of income and growth diversification, especially for rand-hedged exposure beyond local cyclicals. Keep an eye on USD/ZAR moves that could affect returns.
- ABT
- USD/ZAR
- Rand weakness eroding USD returns
- Healthcare regulation changes affecting growth
6/10
Abbott Laboratories is positioned for significant growth potential, with analyst projections suggesting the stock could reach approximately $210 per share by 2036 based on conservative 8% annual earnings growth. The healthcare company's strong track record includes a 9.7% compound annual earnings-per-share growth rate over the past decade, bolstered by strategic acquisitions. Abbott's status as a Dividend King with 54 consecutive years of dividend increases, combined with a 2.5% dividend yield, makes it an attractive option for income-focused investors seeking defensive holdings with upside potential.
Our take is based on reporting first published by The Motley Fool.